Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

236
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

142
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Tangeretin protects renal tubular epithelial cells against experimental cisplatin toxicity

Pages

  179-186

Abstract

 Objective(s): Cisplatin is an effective antineoplastic agent; its clinical utility, however, is limited by a few salient toxic side effects like Nephrotoxicity. This study aimed to determine the potential protective effects of Tangeretin, a citrus-derived flavonoid, against renal tubular cell injury in Cisplatin-induced renal toxicity of rats. Materials and Methods: Tangeretin was injected intraperitoneally at 2. 5 and 5 mg/kg doses for 10 days, and a single dose of Cisplatin (8 mg/kg) was injected on the 7th day. Tests of kidney function and Tubular injury in renal tissues and urine together with oxidative stress and inflammation markers were examined. Results: Tangeretin ameliorated Cisplatin-induced elevations in serum creatinine, BUN, and histopathologic changes. It also attenuated kidney oxidative stress elicited by Cisplatin as demonstrated by reduced MDA and increased GSH, CAT, and SOD activities, elevated Nrf2 expression and protein levels of its downstream effectors, HO-1 and NQO-1. Tangeretin further alleviated inflammation evoked by Cisplatin as indicated by reduced NF-κ B p65 subunit phosphorylation with a simultaneous decrement in its downstream effectors IL-1β and TNF-α expression and protein levels. Moreover, it declined caspase-3 protein levels and TUNEL positive cells in the kidneys, the markers of apoptosis and DNA fragmentation, thus improving renal endurance. Additionally, Tangeretin mitigated renal levels of KIM-1 and NGAL, as well as urinary cystatin C and β 2-microglobulin concentrations, the markers of renal Tubular injury. Conclusion: Collectively, these data signify the binary profit of Tangeretin: enhancement of renal protective mechanisms against Cisplatin and attenuation of renal tubular cell injuries induced by the agent.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Nazari Soltan Ahmad, Saeed, RASHTCHIZADEH, NADEREH, ARGANI, HASSAN, ROSHANGAR, LEILA, GHORBANIHAGHJO, AMIR, Sanajou, Davoud, PANAH, FATEMEH, Ashrafi Jigheh, Zahra, DASTMALCHI, SIAVOUSH, & Kalantary Charvadeh, Ashkan. (2019). Tangeretin protects renal tubular epithelial cells against experimental cisplatin toxicity. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 22(2), 179-186. SID. https://sid.ir/paper/734200/en

    Vancouver: Copy

    Nazari Soltan Ahmad Saeed, RASHTCHIZADEH NADEREH, ARGANI HASSAN, ROSHANGAR LEILA, GHORBANIHAGHJO AMIR, Sanajou Davoud, PANAH FATEMEH, Ashrafi Jigheh Zahra, DASTMALCHI SIAVOUSH, Kalantary Charvadeh Ashkan. Tangeretin protects renal tubular epithelial cells against experimental cisplatin toxicity. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES[Internet]. 2019;22(2):179-186. Available from: https://sid.ir/paper/734200/en

    IEEE: Copy

    Saeed Nazari Soltan Ahmad, NADEREH RASHTCHIZADEH, HASSAN ARGANI, LEILA ROSHANGAR, AMIR GHORBANIHAGHJO, Davoud Sanajou, FATEMEH PANAH, Zahra Ashrafi Jigheh, SIAVOUSH DASTMALCHI, and Ashkan Kalantary Charvadeh, “Tangeretin protects renal tubular epithelial cells against experimental cisplatin toxicity,” IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol. 22, no. 2, pp. 179–186, 2019, [Online]. Available: https://sid.ir/paper/734200/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top